查看文章

Dana J Lukin, Aaron Weiss, Satimai Aniwan, Siri Kadire, Gloria Tran, Mahmoud Rahal, David Faleck, Adam Winters, Shreya Chablaney, Joseph Meserve, Gursimran Kochhar, Preeti Shashi, Jenna L Koliani-Pace, Matthew Bohm, Sashivar Sagi, Monika Fischer, Brigid S Boland, Siddharth Singh, Robert Hirten, Eugenia Shmidt, David Hudesman, Shannon Chang, Sultan Keith, Arun Swaminath, Nitin Gupta, Sunanda V Kane, Edward V Loftus, Bo Shen, Bruce E Sands, William J Sandborn, Jean Frederic Colombel, Corey A Siegel, Parambir Dulai

2018

Gastroenterology

6

154

S-68

277 - Comparative Safety Profile of Vedolizumab and Tumor Necrosis Factor-Antagonist Therapy for Inflammatory Bowel Disease: A Multicenter Consortium Propensity Score-Matched Analysis × Close The Infona portal uses cookies, ie strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser. I accept Polski English Login or …